Evaxion Biotech A/S - American Depositary Shares, each representing fifty Ordinary Shares, DKK 0.25 nominal value per share (EVAX)

11 filings reported holding EVAX - Evaxion Biotech A/S - American Depositary Shares, each representing fifty Ordinary Shares, DKK 0.25 nominal value per share as of Q4 2024.
Evaxion Biotech A/S - American Depositary Shares, each representing fifty Ordinary Shares, DKK 0.25 nominal value per share (EVAX) has 9 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 806K shares of 316M outstanding shares and own 0.26% of the company stock.
Largest 10 shareholders include Merck & Co., Inc. (542K shares), ARMISTICE CAPITAL, LLC (150K shares), Invst, LLC (50.4K shares), Catalina Capital Group, LLC (34.9K shares), MILLENNIUM MANAGEMENT LLC (22.5K shares), Beacon Capital Management, LLC (4.86K shares), JPMORGAN CHASE & CO (780 shares), RHUMBLINE ADVISERS (290 shares), SouthState Corp (4 shares), and CITADEL ADVISORS LLC (0 shares).
This table shows the top 9 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.